Modulation of the action of insulin by angiotensin-(1-7). (Q38180800)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24450744%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

Modulation of the action of insulin by angiotensin-(1-7) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24450744%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24450744%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Valeria Burghi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24450744%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Marina C Muñoz

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24450744%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Jorge F Giani

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24450744%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

language of work or name

English

0 references

publication date

1 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24450744%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24450744%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24450744%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24450744%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

613-630

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24450744%20AND%20SRC:MED&resulttype=core&format=json

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

5 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

From mice to men: insights into the insulin resistance syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

The metabolic syndrome: time to get off the merry-go-round?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Cross-talk between the insulin and angiotensin signaling systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Suppressor of cytokine signaling-3 Provides a novel interface in the cross-talk between angiotensin II and insulin signaling systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

The cross-talk between angiotensin and insulin differentially affects phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-mediated signaling in rat heart: implications for insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

The multi-faceted cross-talk between the insulin and angiotensin II signaling systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

The crosstalk between insulin and renin-angiotensin-aldosterone signaling systems and its effect on glucose metabolism and diabetes prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Epinephrine-induced insulin resistance in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Leptin revisited: its mechanism of action and potential for treating diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Improvement of insulin sensitivity by antagonism of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Activation of mTOR/p70S6 kinase by ANG II inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Inhibition of renin-angiotensin system: implications for diabetes control and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Imidapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance in the Zucker fatty rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin-(1-7): pharmacological properties and pharmacotherapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin-(1-7) in kidney disease: a review of the controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin-(1-7): beyond the cardio-renal actions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Association of plasma angiotensin-(1-7) level and left ventricular function in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

The pregnancy-induced increase of plasma angiotensin-(1–7) is blunted in gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

ACE2 and ANG-(1-7) in the rat uterus during early and late gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin converting enzyme 2: a new important player in the regulation of glycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

The insulin receptor: both a prototypical and atypical receptor tyrosine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Critical nodes in signalling pathways: insights into insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Involvement of Janus kinases in the insulin signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

The phosphoinositide 3-kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

AKT/PKB signaling: navigating downstream

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

SHPTP2 serves adapter protein linking between Janus kinase 2 and insulin receptor substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Stat5 is a physiological substrate of the insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Opposite effect of JAK2 on insulin-dependent activation of mitogen-activated protein kinases and Akt in muscle cells: possible target to ameliorate insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

MAP kinase pathways: the first twenty years

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Signalling by insulin and IGF receptors: supporting acts and new players

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Regulation of insulin receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Increased in vivo phosphorylation of insulin receptor at serine 994 in the liver of obese insulin-resistant Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Identification of serines-1035/1037 in the kinase domain of the insulin receptor as protein kinase C alpha mediated phosphorylation sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Identification of Ser-1275 and Ser-1309 as autophosphorylation sites of the insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Regulation of the insulin receptor by protein kinase C isoenzymes: preferential interaction with β isoenzymes and interaction with the catalytic domain of βII

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

TANK-binding kinase 1 mediates phosphorylation of insulin receptor at serine residue 994: a potential link between inflammation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307)

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

JNK1 and IKKbeta: molecular links between obesity and metabolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin-(1 7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin-(1-7) stimulates the phosphorylation of Akt in rat extracardiac tissues in vivo via receptor Mas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Time-resolved quantitative phosphoproteomics: new insights into Angiotensin-(1-7) signaling networks in human endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin II utilizes Janus kinase 2 in hypertension, but not in the physiological control of blood pressure, during low-salt intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin II-induced signaling pathways in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin II induces tyrosine phosphorylation of insulin receptor substrate 1 and its association with phosphatidylinositol 3-kinase in rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

The insulin signalling system and the IRS proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

The insulin receptor substrate (IRS) proteins: at the intersection of metabolism and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin II stimulation of phospholipase D in rat renal mesangial cells is mediated by the AT1 receptor subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Pharmacological concentration of angiotensin-(1-7) activates NADPH oxidase after ischemia-reperfusion in rat heart through AT1 receptor stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Modulation of the (Na(+)+K+)ATPase activity by Angiotensin-(1-7) in MDCK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Downregulation of the AT1A receptor by pharmacologic concentrations of Angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin-(1-7) reduces renal angiotensin II receptors through a cyclooxygenase-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Molecular Mechanisms Involved in the Angiotensin-(1-7)/Mas Signaling Pathway in Cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Captopril intake decreases body weight gain via angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Control of adipogenesis by the autocrine interplays between angiotensin 1-7/Mas receptor and angiotensin II/AT1 receptor signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Activation of the ACE2/angiotensin-(1-7)/Mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin-(1-7) stimulates high atrial pacing-induced ANP secretion via Mas/PI3-kinase/Akt axis and Na+/H+ exchanger

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Class II phosphoinositide 3-kinase regulates exocytosis of insulin granules in pancreatic beta cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Insulin-feedback via PI3K-C2alpha activated PKBalpha/Akt1 is required for glucose-stimulated insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Endothelial dysfunction and elevated blood pressure in MAS gene-deleted mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Glycogen synthase kinase 3: more than a namesake

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

AS160 regulates insulin- and contraction-stimulated glucose uptake in mouse skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

AS160 deficiency causes whole-body insulin resistance via composite effects in multiple tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin-(1-7) suppresses oxidative stress and improves glucose uptake via Mas receptor in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. A putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Regulation of glucose transport and glycogen synthesis in L6 muscle cells during oxidative stress. Evidence for cross-talk between the insulin and SAPK2/p38 mitogen-activated protein kinase signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

FoxOs at the crossroads of cellular metabolism, differentiation, and transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Nutrient availability and growth: regulation of insulin signaling by dFOXO/FOXO1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin (1-7) counteracts the negative effect of angiotensin II on insulin signalling in HUVECs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

ANG-(1-7) reduces ANG II-induced insulin resistance by enhancing Akt phosphorylation via a Mas receptor-dependent mechanism in rat skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin II and the development of insulin resistance: implications for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

ANG II type I receptor antagonism improved nitric oxide production and enhanced eNOS and PKB/Akt expression in hearts from a rat model of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Increased expression of NAD(P)H oxidase in islets of animal models of Type 2 diabetes and its improvement by an AT1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-kappaB activation via NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Direct inhibition by angiotensin II of insulin-dependent glucose transport activity in mammalian skeletal muscle involves a ROS-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

p38 mitogen-activated protein kinase-dependent transactivation of ErbB receptor family: a novel common mechanism for stress-induced IRS-1 serine phosphorylation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Mechanisms of reactive oxygen species-dependent downregulation of insulin receptor substrate-1 by angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Insulin-induced Akt activation is inhibited by angiotensin II in the vasculature through protein kinase C-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin-(1-7) inhibits angiotensin II-induced signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Insulin transport across capillaries is rate limiting for insulin action in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Losartan increases muscle insulin delivery and rescues insulin's metabolic action during lipid infusion via microvascular recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin 1-7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Decreased hepatic gluconeogenesis in transgenic rats with increased circulating angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Increased circulating angiotensin-(1–7) protects white adipose tissue against development of a proinflammatory state stimulated by a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Antihypertensive therapy and incidence of type 2 diabetes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Possible involvement of angiotensin-converting enzyme 2 and Mas activation in inhibitory effects of angiotensin II Type 1 receptor blockade on vascular remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Pancreatic angiotensin-converting enzyme 2 improves glycemia in angiotensin II-infused mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Direct evidence for intrarenal chymase-dependent angiotensin II formation on the diabetic renal microvasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin-(1-7) Mas-receptor deficiency decreases peroxisome proliferator-activated receptor gamma expression in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

The angiotensin-(1-7) receptor agonist AVE0991 is cardioprotective in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin-converting enzyme 2 activation improves endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin-(1-7) improves cardiac remodeling and inhibits growth-promoting pathways in the heart of fructose-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Ameliorative potential of angiotensin1-7/Mas receptor axis in streptozotocin-induced diabetic nephropathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Attenuating effect of angiotensin-(1-7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-A(y)/Ta mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin-(1-7) prevents diabetes-induced attenuation in PPAR-gamma and catalase activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Characterization of Angiotensin-(1-7) effects on the cardiovascular system in an experimental model of type-1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

ACE2 and Ang-(1-7) confer protection against development of diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Accelerated healing of diabetic wounds by NorLeu(3)-angiotensin (1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Study of angiotensin-(1-7) vasoactive peptide and its beta-cyclodextrin inclusion complexes: complete sequence-specific NMR assignments and structural studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Oral Angiotensin-(1-7) prevented obesity and hepatic inflammation by inhibition of resistin/TLR4/MAPK/NF-κB in rats fed with high-fat diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Oral formulation of angiotensin-(1-7) improves lipid metabolism and prevents high-fat diet-induced hepatic steatosis and inflammation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

Angiotensin II Stimulates Tyrosine Phosphorylation and Activation of Insulin Receptor Substrate 1 and Protein-tyrosine Phosphatase 1D in Vascular Smooth Muscle Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

The Role of Phosphoinositide 3-Kinase C2α in Insulin Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130333